Wikidata

(Q63817385)

English

A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

clinical trial

In more languages

Statements

title
A Randomised, Double-blind, Placebo-controlled, Phase IIa Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) in Patients With Uncomplicated, Gram-positive, Skin Infection (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
cellulitis
0 references
country
Hungary
0 references
start time
September 2010
0 references
end time
February 2011
0 references
number of participants
24
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63817385&oldid=1857410980"